QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
Conclusion: QSYQ ameliorated myocardial I/R injury via suppressing excessive autophagy and NLRP3 Inflammasome.
Source: Frontiers in Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Captopril | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Databases & Libraries | Drugs & Pharmacology | Genetics | Heart | Heart Attack